Summary
-
Benitec Biopharma (BNTC) shows strong technical indicators with 100% buy signals, a 127.84+ Weighted Alpha, and a 190.67% gain in the last year.
The Barchart Brief: Your FREE insider update on the biggest news stories and investing trends, delivered midday The stock is above its 20, 50, and 100-day moving averages, with 11 new highs and a 42.86% increase in the last month.
Wall Street analysts have issued 7 strong buy opinions with price targets between $17 and $25.43, indicating a potential 75% gain.
Despite strong technicals, Barchart highlights the stock's volatility and recommends a disciplined approach with diversification and regular stop-loss reevaluation.
